23andMe shutters cancer drug research, lays off 40% of staff

Nov 12, 2024  · 23andMe shutters cancer drug research programs, lays off 40% of staff. 23andMe is shutting down its therapeutics development division and plans to seek out buyers to find a …


Install CouponFollow Chrome Extension   CouponFollow Extension

40%
OFF

23andMe Shutters Cancer Drug Research, Lays Off 40% Of Staff

6 days from now

Nov 12, 2024  · 23andMe shutters cancer drug research programs, lays off 40% of staff. 23andMe is shutting down its therapeutics development division and plans to seek out buyers to find a …

fiercebiotech.com

40%
OFF

23andMe Cuts 40% Of Its Workforce And Discontinues Therapeutics ...

6 days from now

Nov 12, 2024  · Last month, 23andMe completed a 1-for-20 reverse stock split. Shares were down nearly 4% by midday Tuesday, sitting at around $4.43. 23andMe is laying off 40% of its …

go.com

40%
OFF

23andMe Cuts 40% Of Workforce, Shuts Down Therapeutics Division

6 days from now

6 days ago  · 23andMe, the popular genetic testing company, has announced it will lay off 40% of its workforce, affecting over 200 employees, and shut down its therapeutics division as part of …

techstory.in

40%
OFF

23andMe Cuts 40% Of Staff, Shutters Drug Development Ahead Of …

6 days from now

Nov 12, 2024  · 23andMe (ME) announced a 40% staff reduction and the shuttering of its drug development business, ahead of its Q2 FY25 print. The genetic testing company is laying off …

nasdaq.com

40%
OFF

23andMe Cuts 40% Of Its Workforce And Discontinues Therapeutics …

6 days from now

Nov 12, 2024  · By WYATTE GRANTHAM-PHILIPS, AP Business Writer Nov 12, 2024. NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and …

ctinsider.com

40%
OFF

23andMe Layoffs: Shutters Cancer Drug Research, Cuts 40% Of …

6 days from now

November 12, 2024. Consumer genetics company 23andMe has announced significant restructuring, including the closure of its therapeutics development division and a substantial …

siliconvalleyjournals.com

40%
OFF

23andMe Lays Off 40% Of Staff, Shuts Drug Development Business

6 days from now

Photo: Peter DaSilva/Reuters. DNA-testing company 23andMe ME 19.08% said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief Executive Anne …

wsj.com

40%
OFF

23andMe Lays Off 40% Of Its Employees, Ends Therapy Programs

6 days from now

Nov 12, 2024  · Stat: The End Of 23andMe’s Drug Discovery Dream 23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal …

kffhealthnews.org

40%
OFF

23andMe Lays Off 40% Of Staff, Shuts Drug Development Business …

6 days from now

D NA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief Executive Anne Wojcicki seeks to stabilize her money-losing …

msn.com

40%
OFF

23andMe Shutters Cancer Drug Research Programs, Lays Off 40% Of …

6 days from now

November 12, 2024 San Francisco Biotechnology Network News News, Syndication Comments Off on 23andMe shutters cancer drug research programs, lays off 40% of staff 23andMe is …

sfbn.org

40%
OFF

23andMe Cuts 40% Of Its Workforce And Discontinues Therapeutics ...

6 days from now

Nov 12, 2024  · NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing …

whig.com

40%
OFF

23andMe To Lay Off 40% Of Staff In Desperate Restructuring Effort

6 days from now

Nov 12, 2024  · 23andMe to lay off 40% of staff in desperate restructuring effort The company expects to save $35 million per year after these cuts By Cal Jeffrey November 12, 2024, 16:53

techspot.com

40%
OFF

23andMe To Lay Off 40% Of Employees, Discontinue Therapeutics …

6 days from now

Nov 13, 2024. Genetic testing company 23andMe will lay off more than 200 employees -- 40% of its workforce -- and discontinue its therapeutics division as part of its restructuring program. …

labpulse.com

40%
OFF

23andMe To Lay Off More Than 200 Employees Amid Business …

6 days from now

Nov 13, 2024  · Dive Brief: 23andMe said Monday it will lay off more than 200 employees, about 40% of its staff, and restructure the company amid its financial challenges. The genetic testing …

biopharmadive.com

40%
OFF

23andMe Lays Off 40% Of Staff, Dissolves Therapeutics Division

6 days from now

Nov 12, 2024  · 23andMe is laying off 40% of its workforce and sunsetting its therapeutics programs as part of an effort to streamline operations and reduce costs. The restructuring will …

athletechnews.com

40%
OFF

23andMe To Lay Off 40% Of Its Workforce, Or Around 200 Employees

6 days from now

Nov 12, 2024  · Bay Area genetic testing company 23andMe announced Monday that it plans to lay off 40% of its workforce as part of a broader restructuring effort aimed at cutting costs and …

sfchronicle.com

40%
OFF

23andMe Is Laying Off 40% Of Its Staff And Ending Its Therapeutics …

6 days from now

As a result, 23andMe announced it would lay off 40% of its workforce — or 200 employees — and shutter its therapeutics business, which had focused on cancer drug research. In Its Genes. …

readthejoe.com

40%
OFF

23andMe To Cut 40% Of Its Staff Amid Grim Financials | PCMag

6 days from now

Nov 12, 2024  · DNA testing company 23andMe is laying off 200+ employees, or about 40% of its workforce.. The job cuts are part of a business restructuring to reduce costs, 23andMe …

pcmag.com

FAQs about 23andMe shutters cancer drug research, lays off 40% of staff Coupon?

Is 23andMe laying off employees?

The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on using customers’ DNA data to aid in drug discovery. DNA testing company 23andMe is laying off 200+ employees, or about 40% of its workforce. ...

Is 23andMe shuttering its labs?

"We continue to believe in the promise shown by our clinical and preclinical stage pipeline and will continue to pursue strategic opportunities to continue their development," Wojcicki said. Impacted employees in these divisions still have a little time, as 23andMe indicated that it is not immediately shuttering the labs. ...

What happened to 23andMe me?

Photo: Peter DaSilva/Reuters DNA-testing company 23andMe ME 2.17% said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief Executive Anne Wojcicki seeks to stabilize her money-losing business. ...

Why did 23andMe restructure?

The latest restructuring efforts were announced by 23andMe on Monday. The company said it plans to wind down ongoing clinical trials “as quickly as practical” — and that it was currently evaluating “strategic alternatives” for assets related to its drug development and research programs, which include studies on potential cancer treatments. ...

Will 23andMe restructure its Therapeutics Program?

The restructuring promises to help 23andMe save more than $35 million in annual costs. In addition, 23andMe is hoping it can monetize what’s left of the therapeutics program through “licensing agreements, asset sales or other transactions.” ...

Why did 23andMe close its sister drug discovery unit?

Wojcicki for years touted drug development as central to the company’s strategy to profit from the trove of data that consumers send in to learn about their ancestry. In August, 23andMe said it would close its sister drug discovery unit, which had been tasked with identifying new drug candidates. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension